P38 Mitogen-activated Protein (Map) Kinase Inhibitor (SB-681323)Study In Patients With Neuropathic Pain

This study has been completed.

Study NCT00390845 Information provided by GlaxoSmithKline

First Received: October 18, 2006 Last Updated: July 22, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	August 2008
Primary Completion Date:	August 2008 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: July 22, 2009